Want to learn about the moves HRSA is making to defend 340B rules? If your answer is “yes,” you’re in the right place. In May 2021, Diana...

As you may know, six drug manufacturers cut off 340B savings towards the end of 2020. Many 340B providers lost the savings they need to...

Want to improve your contract pharmacy relationships? Would you like to maximize your 340B savings while staying 340B compliant each...

Would you like to remain compliant while optimizing your 340B savings potential? The truth is. Your compliance team must be up-to-date on...

Want to stay HRSA compliant? Keeping your information up to date in the 340B Drug Pricing Program’s OPAIS database will help you maintain...

Most of you know that the 340B program is heavily scrutinized by lawmakers today. Their main concerns are the lack of transparency on how...

If you have been following the trials, tribulations and changes within 340B throughout the 2020 year...

Imagine opening and running a restaurant with no experience or resources. For sure, it’s a huge commitment that involves getting proper...

Did you know that 71% of all HRSA audits result in findings? Is your organization prepared to pass a surprise HRSA audit if they notified...

Download our slides for Optimal340B's tips and techniques for 340B best practices!

Imagine having unlimited access to pharmacy patients without extra work on your part. Telepharmacy makes it easy for you to: Reach more...

As anyone that has been involved in the 340B Drug Pricing Program for any real amount of time knows, change really is one of the only consta

Q: How do independent pharmacies benefit from 340B relationships? Independent pharmacies can obtain an enhanced dispensing fee on 340B...

Your 340B program is essential to your FQHC’s success. An optimized 340B program will help you stretch your dollars and increase revenue.

The federal agency responsible for overseeing Big Pharma and 340B programs, has suspiciously turned a blind eye to recent attacks on 340B Dr

Financial challenges are the number one issue hospital CEOs face, according to The American College of Healthcare Executives (ACHE)....

The new platform analyzes pharmacy dispensation records to find errors and missed claims.

The American Hospital Association (AHA) has just released letters to five leading U.S drug companies. Turns out, these companies may have be

In a recent post by Adam J. Fein, CEO of Drug Channels Institute, he shares insight on why the 340B Drug Pricing Program needs to become a "

Omnicell is already a leading provider of prescription drug chain products and services. Now, they've purchased PSG's 340B line of business